True North Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,000
Closed -$20.4K 230
2023
Q1
$20.4K Hold
14,000
0.01% 194
2022
Q4
$17.5K Hold
14,000
0.01% 172
2022
Q3
$26K Hold
14,000
0.01% 183
2022
Q2
$35K Hold
14,000
0.01% 195
2022
Q1
$48K Hold
14,000
0.01% 196
2021
Q4
$67K Hold
14,000
0.01% 234
2021
Q3
$51K Hold
14,000
0.01% 220
2021
Q2
$56K Hold
14,000
0.01% 217
2021
Q1
$60K Hold
14,000
0.01% 204
2020
Q4
$55K Hold
14,000
0.01% 192
2020
Q3
$51K Hold
14,000
0.01% 183
2020
Q2
$47K Hold
14,000
0.01% 186
2020
Q1
$18K Hold
14,000
0.01% 123
2019
Q4
$20K Buy
+14,000
New +$23.4K 0.01% 121

Other funds holding OPK

True North Advisors's OPK Position: Q2 2023 in Review

True North Advisors sold out of Opko Health (OPK) in Q2 2023, closing a stake of 14,000 shares — an estimated $20.4K sold.

True North Advisors first reported a position in OPK in Q4 2019 and held it in 14 quarters. The position peaked at $67K in Q4 2021. 230 funds tracked by Wall St. Rank hold OPK as of Q2 2023.

  • True North Advisors reported no remaining Opko Health position as of Q2 2023 after selling out during the quarter.
  • True North Advisors sold 14,000 Opko Health shares in Q2 2023, an estimated $20.4K.
  • True North Advisors first reported a position in Opko Health in Q4 2019 and held it in 14 quarters.
  • True North Advisors's Opko Health position peaked at $67K in Q4 2021.
  • 230 funds tracked by Wall St. Rank held Opko Health as of Q2 2023.

Based on True North Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.